TDMS Study 92012-03 Pathology Tables
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
90-DAY SUBCHRONIC
Facility: Microbiological Associates
Chemical CAS #: 693-98-1
Lock Date: 08/31/94
Cage Range: All
Reasons For Removal: All
Removal Date Range: All
Treatment Groups: Include All
a Number of animals examined microscopically at site and number of animals with lesion
Page 1
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
____________________________________________________________________________________________________________________________________
FISCHER 344 RATS FEMALE UNTREAT 625 1250 2500 5000 10000
CONTROL PPM PPM PPM PPM PPM
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 10 10 10 10 10 10
Early Deaths
Survivors
Accidently Killed 3 3 2 5
Terminal Sacrifice 7 10 10 7 8 5
Animals Examined Microscopically 10 10 10 10 10 10
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 2
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
____________________________________________________________________________________________________________________________________
FISCHER 344 RATS FEMALE UNTREAT 625 1250 2500 5000 10000
CONTROL PPM PPM PPM PPM PPM
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 3
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
____________________________________________________________________________________________________________________________________
FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000
CONTROL PPM PPM PPM PPM PPM
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 10 10 10 10 10 10
Early Deaths
Survivors
Terminal Sacrifice 10 10 10 10 10 10
Animals Examined Microscopically 10 10 10 10 10 10
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
Thyroid Gland (10) (10) (10) (10) (10) (10)
Follicular Cell, Adenoma 2 (20%)
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 4
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
____________________________________________________________________________________________________________________________________
FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000
CONTROL PPM PPM PPM PPM PPM
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 5
NTP Experiment-Test: 92012-03 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: SUBCHRON 90-DAY 2-METHYLIMIDAZOLE Date: 08/06/96
Route: DOSED FEED Time: 15:20:50
____________________________________________________________________________________________________________________________________
FISCHER 344 RATS MALE UNTREAT 625 1250 2500 5000 10000
CONTROL PPM PPM PPM PPM PPM
____________________________________________________________________________________________________________________________________
TUMOR SUMMARY
Total Animals with Primary Neoplasms (b) 2
Total Primary Neoplasms 2
Total Animals with Benign Neoplasms 2
Total Benign Neoplasms 2
Total Animals with Malignant Neoplasms
Total Malignant Neoplasms
Total Animals with Metastatic Neoplasms
Total Metastatic Neoplasm
Total Animals with Malignant Neoplasms
Uncertain Primary Site
Total Animals with Neoplasms Uncertain-
Benign or Malignant
Total Uncertain Neoplasms
____________________________________________________________________________________________________________________________________
a Number of animals examined microscopically at site and number of animals with lesion
b Primary tumors: all tumors except metastatic tumors
Page 6
------------------------------------------------------------
---------- END OF REPORT ----------
------------------------------------------------------------